Track topics on Twitter Track topics that are important to you
Hollis-Eden Pharmaceuticals is a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of a number of targeted disease states caused byviral, bacterial, parasitic or fungal infections, including HIV/AIDS, hepatitis B and C, and malaria. The Company has three technology platforms, one based on cellular energy regulation, the second on a unique immune system modulation technology, and the third on biochemical synthesis regulators. The Company believes that certain of its drug candidates may provide the first long-term treatment for HIV without the development of viral strain resistance to the drugs' effectiveness, significant toxicity or severe side effects.
4435 Eastgate Mall
United States of America
Savannah Hollis, a healthy three-sport athlete who had just turned 21, was one week into her senior year at the University of Louisiana at Lafayette when a sudden internal bleeding episode near...
Photostability testing of pharmaceuticals, combination products, cosmetics and other products now available at Eden Prairie, MN facility EDEN PRAIRIE, Minn. (PRWEB) November 15, 2017 DDL, Inc. announ...
Eden Prairie, MN (PRWEB) September 29, 2017 Dr. Andres R. Sanchez, a well-known periodontist with PerioWest, recently completed a co...
The suspect was taken into custody Monday night and identified as 19 year-old Hollis Daniels
ATLANTA, Sept. 21, 2017 /PRNewswire/ -- OrthoAtlanta is pleased to welcome Minoo H. Hollis, M.D., to its orthopedic and sports medicine practice in Stockbridge, Georgia, bringing expertise in foo...
The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both using the Instant F...
Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.
EDEN PRAIRIE, Minn., June 29, 2017 (GLOBE NEWSWIRE) Read more...
equaline anti-itch cream
Last year, for the ﬁrst time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the ﬁeld of medicinal chemistry.
This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...
More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...
The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...
This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.
Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinnett (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.
Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition
- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...
Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...
This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...
Hollis-Eden Pharmaceuticals is a development-stage company with two product candidates in clinical trials: Apoptone® (HE3235), in the dose-escalation portion of a Phase I/II trial of patients with la...
Hollis-Eden Pharmaceuticals is a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of a number of targeted disease ...
Civic Leader of the Year: Peter Crouch, RPh, CCP, Eden Drug, Eden, N.C.
Eden Biodesign is a globally-integrated biopharmaceutical company offering consultancy, biopharmaceutical design, process development and cGMP manufacturing services to leading bi...
Eden Biodesign is an integrated biopharmaceutical development organisation that evolved out of Eden Biopharm, a successful international development and manufacturing consultancy. Eden Biodesign is th...
We have published hundreds of Hollis-Eden Pharmaceuticals news stories on BioPortfolio along with dozens of Hollis-Eden Pharmaceuticals Clinical Trials and PubMed Articles about Hollis-Eden Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hollis-Eden Pharmaceuticals Companies in our database. You can also find out about relevant Hollis-Eden Pharmaceuticals Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...